Journal of the Neurological Sciences
Volume 222, Issue 1 , Pages 13-19, 15 July 2004

High-dose, frequently administered interferon beta therapy for relapsing–remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study

Divisione di Neurologia, Ospedale San Luigi Gonzaga, Regione Gonzole, Via Cherasco, 15, 10-I 10043 Orbassano, Turin, Italy

Received 23 July 2003; received in revised form 19 March 2004; accepted 20 March 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0022-510X(04)00091-7

doi:10.1016/j.jns.2004.03.023

Journal of the Neurological Sciences
Volume 222, Issue 1 , Pages 13-19, 15 July 2004

Article Tools

* Image Usage & Resolution